According to IVERIC bio's latest financial reports the company's current earnings (TTM) are -$0.23 B. In 2022 the company made an earning of -$0.19 B a decrease over its 2021 earnings that were of -$0.12 B.The earnings displayed on this page is the company's Pretax Income.
Year | Earnings | Change |
---|---|---|
2023 (TTM) | -$0.23 B | 20.35% |
2022 | -$0.19 B | 61.73% |
2021 | -$0.12 B | 29.78% |
2020 | -$88.25 M | 49.64% |
2019 | -$58.97 M | -195.08% |
2018 | $62.02 M | -43.35% |
2017 | $0.10 B | -156.49% |
2016 | -$0.2 B | 58.22% |
2015 | -$0.13 B | 52.57% |
2014 | -$80.3 M | 57% |
2013 | -$51.15 M |
Company | Earnings | Earnings differencediff. | Country |
---|---|---|---|
ORIC Pharmaceuticals
ORIC | -$0.12 B | -50.30% | ๐บ๐ธ USA |